Ftse Mib
34.414,64
0,11%
DAX
18.532,49
-0,36%
S&P 500
5.654,96
0,42%
NASDAQ
18.473,24
0,00%
Bitcoin
63.914,13
-1,45%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
17/06/202113:32Dow Jones NewsApplied Therapeutics Gets FDA Fast-Track Designation for AT-007 in GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
17/06/202113:00GlobeNewswire Inc.Applied Therapeutics Granted Fast Track Designation by FDA for AT-007 for GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
05/06/202101:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APLTApplied Therapeutics Inc
04/06/202122:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APLTApplied Therapeutics Inc
01/06/202113:00GlobeNewswire Inc.Applied Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
19/05/202113:00GlobeNewswire Inc.Applied Therapeutics to Present at the UBS Global Healthcare Virtual ConferenceNASDAQ:APLTApplied Therapeutics Inc
11/05/202114:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
11/05/202113:00GlobeNewswire Inc.Applied Therapeutics Reports First Quarter 2021 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
16/04/202122:39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APLTApplied Therapeutics Inc
07/04/202113:00GlobeNewswire Inc.Applied Therapeutics to Present Cross-Sectional Analysis of Galactosemia Disease Progression at 2021 Annual Clinical Genetics...NASDAQ:APLTApplied Therapeutics Inc
02/04/202123:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:APLTApplied Therapeutics Inc
18/03/202113:21Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APLTApplied Therapeutics Inc
18/03/202112:00GlobeNewswire Inc.Applied Therapeutics Reports Fourth Quarter and Year-End 2020 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
16/03/202112:00GlobeNewswire Inc.Applied Therapeutics to Host Virtual Rare Disease ForumNASDAQ:APLTApplied Therapeutics Inc
23/02/202113:00GlobeNewswire Inc.Applied Therapeutics to Present at the Cowen and Barclays Investor ConferencesNASDAQ:APLTApplied Therapeutics Inc
22/02/202113:00GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Closing of Public OfferingNASDAQ:APLTApplied Therapeutics Inc
13/02/202100:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APLTApplied Therapeutics Inc
12/02/202123:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APLTApplied Therapeutics Inc
12/02/202100:51GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Pricing of Public Offering of 3,000,000 Shares of Common StockNASDAQ:APLTApplied Therapeutics Inc
10/02/202122:07GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Offering of 3,000,000 Shares of Common StockNASDAQ:APLTApplied Therapeutics Inc
01/02/202113:00GlobeNewswire Inc.Applied Therapeutics Announces Restart of Pediatric Galactosemia StudyNASDAQ:APLTApplied Therapeutics Inc
15/12/202014:00GlobeNewswire Inc.Applied Therapeutics to be Added to NASDAQ Biotechnology IndexNASDAQ:APLTApplied Therapeutics Inc
09/12/202014:15GlobeNewswire Inc.Applied Therapeutics Announces Launch of Galactosemia Awareness and Education InitiativeNASDAQ:APLTApplied Therapeutics Inc
09/12/202013:00GlobeNewswire Inc.Applied Therapeutics Announces MRS Data from ACTION-Galactosemia StudyNASDAQ:APLTApplied Therapeutics Inc
12/11/202013:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2020 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
09/11/202013:00GlobeNewswire Inc.Applied Therapeutics Announces Presentation of Pre-Clinical Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at th...NASDAQ:APLTApplied Therapeutics Inc
21/10/202013:00GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-007 for the Treatment of Galactosemia at the American Society of Human Genetics (A...NASDAQ:APLTApplied Therapeutics Inc
05/10/202019:00GlobeNewswire Inc.180 Life Science Corp. Announces New Board of Directors AppointmentsNASDAQ:APLTApplied Therapeutics Inc
24/09/202014:00GlobeNewswire Inc.FDA Grants AT-007 Pediatric Rare Disease Designation and Orphan Designation for Treatment of PMM2-CDGNASDAQ:APLTApplied Therapeutics Inc
17/09/202013:00GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-001 for Treatment of Diabetic Cardiomyopathy at 56th Annual Meeting of the Europea...NASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

AQSE
COG.GB
Cambridge Cognition
BIT
UB4Q5W
Unicredit Bank
LSE
87OE
Bluestone C
LSE
ANRJ
Amundiglblhdrgn
NYSE
CBL
CBL and Associates Prope...
NASDAQ
RNST
Renasant
BOV
UNIP6
UNIPAR PNB
USOTC
CHYL
China Senior Living Indu... (CE)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network